These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study. Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C Front Immunol; 2020; 11():581338. PubMed ID: 33123167 [TBL] [Abstract][Full Text] [Related]
12. Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection. Horspool AM; Kieffer T; Russ BP; DeJong MA; Wolf MA; Karakiozis JM; Hickey BJ; Fagone P; Tacker DH; Bevere JR; Martinez I; Barbier M; Perrotta PL; Damron FH mSphere; 2021 Jan; 6(1):. PubMed ID: 33472985 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic targeting of interleukin-6 for the treatment of COVID-19. Wang Y; Liu C; Miao X; Kong D; Zhao Y; Gong W; Ding X Eur Cytokine Netw; 2020 Dec; ():. PubMed ID: 33270024 [TBL] [Abstract][Full Text] [Related]
14. Neutralizing Monoclonal Antibodies That Target the Spike Receptor Binding Domain Confer Fc Receptor-Independent Protection against SARS-CoV-2 Infection in Syrian Hamsters. Su W; Sia SF; Schmitz AJ; Bricker TL; Starr TN; Greaney AJ; Turner JS; Mohammed BM; Liu Z; Choy KT; Darling TL; Joshi A; Cheng KM; Wong AYL; Harastani HH; Nicholls JM; Whelan SPJ; Bloom JD; Yen HL; Ellebedy AH; Boon ACM mBio; 2021 Oct; 12(5):e0239521. PubMed ID: 34517754 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells. Meyer K; Patra T; Vijayamahantesh ; Ray R J Virol; 2021 Aug; 95(17):e0079421. PubMed ID: 34160250 [TBL] [Abstract][Full Text] [Related]
16. Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model. Gu T; Zhao S; Jin G; Song M; Zhi Y; Zhao R; Ma F; Zheng Y; Wang K; Liu H; Xin M; Han W; Li X; Dong CD; Liu K; Dong Z Front Immunol; 2020; 11():621441. PubMed ID: 33584719 [TBL] [Abstract][Full Text] [Related]
17. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab. Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616 [TBL] [Abstract][Full Text] [Related]
18. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy. Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027 [TBL] [Abstract][Full Text] [Related]
19. Tocilizumab as a Treatment for 'Cytokine Storm Syndrome' in COVID-19: A Case Report. Syam AF; Pitoyo CW; Suhendro S; Zulkarnain B; Indrasari ND; Aditianingsih D; Irawan C; Susilo A; Rumende CM; Wijaya IP; Ibrahim F; Rasmin M; Alwi I; Makmun D Acta Med Indones; 2021 Apr; 53(2):194-201. PubMed ID: 34251348 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo efficacy of anti-chikungunya virus monoclonal antibodies produced in wild-type and glycoengineered Nicotiana benthamiana plants. Hurtado J; Acharya D; Lai H; Sun H; Kallolimath S; Steinkellner H; Bai F; Chen Q Plant Biotechnol J; 2020 Jan; 18(1):266-273. PubMed ID: 31207008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]